title: A double-edged sword role for ubiquitin-proteasome system in brain stem cardiovascular regulation during experimental brain death.
abstract: BACKGROUND
  Brain stem cardiovascular regulatory dysfunction during brain death is underpinned by an upregulation of nitric oxide synthase II (NOS II) in rostral ventrolateral medulla (RVLM), the origin of a life-and-death signal detected from blood pressure of comatose patients that disappears before brain death ensues. Furthermore, the ubiquitin-proteasome system (UPS) may be involved in the synthesis and degradation of NOS II. We assessed the hypothesis that the UPS participates in brain stem cardiovascular regulation during brain death by engaging in both synthesis and degradation of NOS II in RVLM.
  
  
  RESULTS
  In a clinically relevant experimental model of brain death using Sprague-Dawley rats, pretreatment by microinjection into the bilateral RVLM of proteasome inhibitors (lactacystin or proteasome inhibitor II) antagonized the hypotension and reduction in the life-and-death signal elicited by intravenous administration of Escherichia coli lipopolysaccharide (LPS). On the other hand, pretreatment with an inhibitor of ubiquitin-recycling (ubiquitin aldehyde) or ubiquitin C-terminal hydrolase isozyme L1 (UCH-L1) potentiated the elicited hypotension and blunted the prevalence of the life-and-death signal. Real-time polymerase chain reaction, Western blot, electrophoresis mobility shift assay, chromatin immunoprecipitation and co-immunoprecipitation experiments further showed that the proteasome inhibitors antagonized the augmented nuclear presence of NF-κB or binding between NF-κB and nos II promoter and blunted the reduced cytosolic presence of phosphorylated IκB. The already impeded NOS II protein expression by proteasome inhibitor II was further reduced after gene-knockdown of NF-κB in RVLM. In animals pretreated with UCH-L1 inhibitor and died before significant increase in nos II mRNA occurred, NOS II protein expression in RVLM was considerably elevated.
  
  
  CONCLUSIONS
  We conclude that UPS participates in the defunct and maintained brain stem cardiovascular regulation during experimental brain death by engaging in both synthesis and degradation of NOS II at RVLM. Our results provide information on new therapeutic initiatives against this fatal eventuality.
authors: Center for Translation Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial Hospital, Taiwan, Republic of China.
authors: Carol H Y
authors: CH
authors: Wu
authors: Julie Y H
authors: JY
authors: Chan
authors: Samuel H H
authors: SH
authors: Chan
authors: Alice Y W
authors: AY
authors: Chang
mesh_terms: D000818:Animals; D001926:Brain Death / Q000378:metabolism* / Q000503:physiopathology*; D001933:Brain Stem / Q000201:enzymology / Q000378:metabolism* / Q000503:physiopathology; D002319:Cardiovascular System / Q000503:physiopathology*; D019446:Endotoxemia / Q000150:complications; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D059748:Proteolysis; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D025801:Ubiquitin / Q000378:metabolism*; D054875:Ubiquitination; D015854:Up-Regulation
chemical_list: D012333:RNA, Messenger; D025801:Ubiquitin; D052247:Nitric Oxide Synthase Type II; D046988:Proteasome Endopeptidase Complex